These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7602341)

  • 1. Long-term complications of cancer chemotherapy.
    Pedersen-Bjergaard J
    J Clin Oncol; 1995 Jul; 13(7):1534-6. PubMed ID: 7602341
    [No Abstract]   [Full Text] [Related]  

  • 2. Does the concurrent use of anthracycline and granulocyte colony-stimulating factor influence the risk of secondary leukaemia in breast cancer women?
    Di Cosimo S; Ferretti G; Papaldo P; Carlini P; Fabi A; Ruggeri EM; Alimonti A; Nardoni C; Cognetti F
    Ann Oncol; 2005 Jul; 16(7):1209-10. PubMed ID: 15857847
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment-related myelodysplastic syndrome/acute myeloid leukemia in survivors of childhood cancer--an update.
    Barnard DR; Woods WG
    Leuk Lymphoma; 2005 May; 46(5):651-63. PubMed ID: 16019502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelodysplastic syndrome and acute myeloid leukemia secondary to mitolactol treatment in patients with breast cancer.
    Bennett JM; Troxel AB; Gelman R; Falkson G; Coccia-Portugal MD; Dreicer R; Tormey DC; Rushing D
    J Clin Oncol; 1994 Apr; 12(4):874-5. PubMed ID: 8151329
    [No Abstract]   [Full Text] [Related]  

  • 5. Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease.
    Tebbi CK; London WB; Friedman D; Villaluna D; De Alarcon PA; Constine LS; Mendenhall NP; Sposto R; Chauvenet A; Schwartz CL
    J Clin Oncol; 2007 Feb; 25(5):493-500. PubMed ID: 17290056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelodysplastic syndrome and acute myeloid leukemia after treatment with fludarabine, mitoxantrone, and dexamethasone.
    Au WY; Chan LC; Liang R; Kwong YL
    Am J Hematol; 2006 Jun; 81(6):471-3. PubMed ID: 16680740
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy-related acute leukaemia and myelodysplastic syndrome].
    Díaz Beveridge R; Aparicio Urtasun J
    An Med Interna; 2003 May; 20(5):257-68. PubMed ID: 12831302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of therapy-related acute myelogenous leukemia and myelodysplastic syndromes.
    Ballen KK; Antin JH
    Hematol Oncol Clin North Am; 1993 Apr; 7(2):477-93. PubMed ID: 8468276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary myelodysplasia and acute leukemia following carboplatin-containing combination chemotherapy for ovarian cancer.
    Colon-Otero G; Malkasian GD; Edmonson JH
    J Natl Cancer Inst; 1993 Nov; 85(22):1858-60. PubMed ID: 8230267
    [No Abstract]   [Full Text] [Related]  

  • 10. Secondary leukaemia after cure for locally advanced NSCLC: alkylating type secondary leukaemia after induction therapy with docetaxel and carboplatin for NSCLC IIIB.
    Griesinger F; Metz M; Trümper L; Schulz T; Haase D
    Lung Cancer; 2004 May; 44(2):261-5. PubMed ID: 15084391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
    Morrison VA; Rai KR; Peterson BL; Kolitz JE; Elias L; Appelbaum FR; Hines JD; Shepherd L; Larson RA; Schiffer CA
    J Clin Oncol; 2002 Sep; 20(18):3878-84. PubMed ID: 12228208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second cancers in chronic lymphocytic leukemia: growing importance in the era of improved treatment outcomes.
    Langerbeins P; Maurer C; Cramer P; Eichhorst B; Hallek M
    Leuk Lymphoma; 2015 Jun; 56(6):1575-6. PubMed ID: 25804766
    [No Abstract]   [Full Text] [Related]  

  • 13. Granulocyte colony-stimulating factor and severe aplastic anemia.
    Alter BP; Rosenberg PS
    Blood; 2007 May; 109(10):4589; author reply 4589-90. PubMed ID: 17483301
    [No Abstract]   [Full Text] [Related]  

  • 14. High incidence of therapy-related myelodysplasia and acute leukaemia in general haematology clinic patients treated with fludarabine and cyclophosphamide for indolent lymphoproliferative disorders.
    Bowcock SJ; Rassam SM; Lim Z; Ward SM; Ryali MM; Mufti GJ
    Br J Haematol; 2006 Jul; 134(2):242-3. PubMed ID: 16846486
    [No Abstract]   [Full Text] [Related]  

  • 15. Hematologic abnormalities and acute myeloid leukemia in children and adolescents administered intensified chemotherapy for the Ewing sarcoma family of tumors.
    Rodriguez-Galindo C; Poquette CA; Marina NM; Head DR; Cain A; Meyer WH; Santana VM; Pappo AS
    J Pediatr Hematol Oncol; 2000; 22(4):321-9. PubMed ID: 10959902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute myeloid leukemia and myelodysplastic syndrome in children treated for cancer: comparison with primary presentation.
    Barnard DR; Lange B; Alonzo TA; Buckley J; Kobrinsky JN; Gold S; Neudorf S; Sanders J; Burden L; Woods WG
    Blood; 2002 Jul; 100(2):427-34. PubMed ID: 12091332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy-related myelodysplasia and fludarabine combination therapy - do the benefits justify the risk?
    Carney DA; Seymour JF
    Leuk Lymphoma; 2010 Nov; 51(11):1957-9. PubMed ID: 20858101
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
    Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etiology of acute myeloid leukemia following intensive therapy for AML--relapse, secondary disease or bad luck?
    Braess J; Schoch C; Fiegl M; Schmid C; Hiddemann W; Kolb HJ
    Leukemia; 2002 Dec; 16(12):2459-62. PubMed ID: 12454756
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
    J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.